Biphenyl-Derived Phosphepines as Chiral Nucleophilic Catalysts: Enantioselective [4+1] Annulations To Form Functionalized Cyclopentenes
Abstract
Because of the frequent occurrence of cyclopentane subunits in bioactive compounds, the development of efficient catalytic asymmetric methods for their synthesis is an important objective. Introduced herein is a new family of chiral nucleophilic catalysts, biphenyl-derived phosphepines, and we apply them to an enantioselective variant of a useful [4+1] annulation. A range of one-carbon coupling partners can be employed, thereby generating cyclopentenes which bear a fully substituted stereocenter [either all-carbon or heteroatom-substituted (sulfur and phosphorus)]. Stereocenters at the other four positions of the cyclopentane ring can also be introduced with good stereoselectivity. An initial mechanistic study indicates that phosphine addition to the electrophilic four-carbon coupling partner is not the turnover-limiting step of the catalytic cycle.
Additional Information
© 2014 Wiley-VCH Verlag GmbH & Co. Received: June 2, 2014. Revised: July 15, 2014. Article first published online: 6 Oct 2014. Support has been provided by the National Institutes of Health (National Institute of General Medical Sciences: R01-GM57034), EMD Serono (fellowship support for D.T.Z.), the Spanish MICINN (fellowship support for L.R.), Daiichi Sankyo Co., Ltd (fellowship support for T.I.), and Dainippon Sumitomo Pharma Co., Ltd. (fellowship support for Y.F.). We thank Trixia Buscagan, Dr. Søren Kramer, Dr. Allen Oliver (University of Notre Dame), Dr. Nathan D. Schley, Dr. Michael K. Takase, Dr. David VanderVelde, Dr. Scott C. Virgil, and Dr. Ashraf Wilsily for assistance and for helpful discussions.Attached Files
Accepted Version - nihms687855.pdf
Supplemental Material - anie_201405854_sm_miscellaneous_information.pdf
Files
Name | Size | Download all |
---|---|---|
md5:62aba8fc343ab108207e3ee237d4a28d
|
506.5 kB | Preview Download |
md5:a2a984a5fd2a6a78c2cab507a06be96f
|
13.0 MB | Preview Download |
Additional details
- PMCID
- PMC4433032
- Eprint ID
- 50426
- Resolver ID
- CaltechAUTHORS:20141015-153508295
- NIH
- R01-GM57034
- EMD Serono
- MICINN Ministerio de Ciencia e Innovación (MICINN)
- Daiichi Sankyo Co., Ltd.
- Dainippon Sumitomo Pharma Co., Ltd.
- Created
-
2014-10-15Created from EPrint's datestamp field
- Updated
-
2021-11-10Created from EPrint's last_modified field